Cargando…
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
Human steroid 5α-reductase 2 (SRD5A2) is an integral membrane enzyme in steroid metabolism and catalyzes the reduction of testosterone to dihydrotestosterone. Mutations in the SRD5A2 gene have been linked to 5α-reductase deficiency and prostate cancer. Finasteride and dutasteride, as SRD5A2 inhibito...
Autores principales: | Xiao, Qingpin, Wang, Lei, Supekar, Shreyas, Shen, Tao, Liu, Heng, Ye, Fei, Huang, Junzhou, Fan, Hao, Wei, Zhiyi, Zhang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591894/ https://www.ncbi.nlm.nih.gov/pubmed/33110062 http://dx.doi.org/10.1038/s41467-020-19249-z |
Ejemplares similares
-
Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020) -
The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017) -
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
por: Kiguradze, Tina, et al.
Publicado: (2017) -
Development of finasteride polymer microspheres for systemic application in
androgenic alopecia
por: Kim, Ju Hee, et al.
Publicado: (2019) -
Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
por: Lin, Zhe-Min, et al.
Publicado: (2020)